Featured Content
During 2017, 2018, 2019 and 2020 we have been delighted to see Gene Therapy content included in a number of Springer Nature collections and campaigns, which contain content from across the Springer Nature portfolio and are a great way to not only showcase the great research that is being published in our journals, but bring wider attention to individual journals and introduce them to more readers. We are excited to see Gene Therapy content be included in more collections and campaigns in 2021 and encourage all to submit their papers to Gene Therapy too and have the opportunity to have their work showcased to Springer Nature's large and global audience.
2020 Global Year for the Prevention of Pain
Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain
Gene Therapy
An important step on the long path to clinical application of in utero gene therapy
Delivering efficient liver-directed AAV-mediated gene therapy
A brief account of viral vectors and their promise for gene therapy
World Aid's Day 2018
Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDs
DNA Day 2018
Non-viral delivery of genome-editing nucleases for gene therapy
Targeted in vivo knock-inof human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9
Human genomics projects and precision medicine
Herpes virusMicroRNAs for use in gene therapy immune-evasion strategies
Precision Medicine
How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy
The clinical landscape for SMA in a new therapeutic era